204 related articles for article (PubMed ID: 16940985)
1. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.
Kubben FJ; Sier CF; Meijer MJ; van den Berg M; van der Reijden JJ; Griffioen G; van de Velde CJ; Lamers CB; Verspaget HW
Br J Cancer; 2006 Sep; 95(6):744-51. PubMed ID: 16940985
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.
Alakus H; Afriani N; Warnecke-Eberz U; Bollschweiler E; Fetzner U; Drebber U; Metzger R; Hölscher AH; Mönig SP
World J Surg; 2010 Dec; 34(12):2853-9. PubMed ID: 20730428
[TBL] [Abstract][Full Text] [Related]
3. The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions.
Collazos J; Asensi V; Martin G; Montes AH; Suárez-Zarracina T; Valle-Garay E
Clin Exp Immunol; 2015 Nov; 182(2):213-9. PubMed ID: 26206176
[TBL] [Abstract][Full Text] [Related]
4. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.
Meijer MJ; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Hommes DW; Verspaget HW
World J Gastroenterol; 2007 Jun; 13(21):2960-6. PubMed ID: 17589947
[TBL] [Abstract][Full Text] [Related]
5. A multigenic approach to evaluate genetic variants of PLCE1, LXRs, MMPs, TIMP, and CYP genes in gallbladder cancer predisposition.
Sharma KL; Rai R; Srivastava A; Sharma A; Misra S; Kumar A; Mittal B
Tumour Biol; 2014 Sep; 35(9):8597-606. PubMed ID: 24863943
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Zhang M; Zhu GY; Gao HY; Zhao SP; Xue Y
J Surg Oncol; 2011 Mar; 103(3):243-7. PubMed ID: 21337552
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
[TBL] [Abstract][Full Text] [Related]
8. Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients.
Martin G; Asensi V; Montes AH; Collazos J; Alvarez V; Carton JA; Taboada F; Valle-Garay E
Sci Rep; 2014 May; 4():5002. PubMed ID: 24833564
[TBL] [Abstract][Full Text] [Related]
9. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
10. Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP-2, MMP-9, MMP-12) and their inhibitor TIMP-2.
Slonková V; Slonková V; Vašků A; Vašků V
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1746-1752. PubMed ID: 28662285
[TBL] [Abstract][Full Text] [Related]
11. Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection.
Hung KH; Hung HW; Yang HB; Lu CC; Wu JJ; Sheu BS
Helicobacter; 2009 Dec; 14(6):580-7. PubMed ID: 19889076
[TBL] [Abstract][Full Text] [Related]
12. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of MMP-3 and TIMP-4 genes affect angiographic coronary plaque progression in non-diabetic and type 2 diabetic patients.
Chen QJ; Lu L; Peng WH; Hu J; Yan XX; Wang LJ; Zhang Q; Zhang RY; Shen WF
Clin Chim Acta; 2009 Jul; 405(1-2):97-103. PubMed ID: 19376102
[TBL] [Abstract][Full Text] [Related]
14. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
Horne BD; Camp NJ; Carlquist JF; Muhlestein JB; Kolek MJ; Nicholas ZP; Anderson JL
Am Heart J; 2007 Oct; 154(4):751-8. PubMed ID: 17893005
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.
Shim KN; Jung SA; Joo YH; Yoo K
J Gastroenterol; 2007 Feb; 42(2):120-8. PubMed ID: 17351800
[TBL] [Abstract][Full Text] [Related]
16. Altered transcripts expression of matrix metalloproteinases and their tissue inhibitors in tenon capsule of patients with glaucoma.
Liu CJ; Huang YL; Ju JP; Lu CL; Chiu AW
J Glaucoma; 2004 Dec; 13(6):486-91. PubMed ID: 15534474
[TBL] [Abstract][Full Text] [Related]
17. Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
Oszajca K; Szemraj M; Szemraj J; Jurowski P
Ophthalmic Genet; 2018 Dec; 39(6):684-698. PubMed ID: 30289322
[TBL] [Abstract][Full Text] [Related]
18. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their inhibitors in gastric cancer.
Murray GI; Duncan ME; Arbuckle E; Melvin WT; Fothergill JE
Gut; 1998 Dec; 43(6):791-7. PubMed ID: 9824606
[TBL] [Abstract][Full Text] [Related]
20. Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma.
Qiao ZK; Li YL; Lu HT; Wang KL; Xu WH
World J Surg Oncol; 2013 Jan; 11():1. PubMed ID: 23281640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
